Novolin Injection, Suspension
Product Images NDC 0169-3004

Product Visual Gallery

This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Novolin (NDC 0169-3004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk Pharmaceutical Industries, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Novolin N Vial Carton (Image 01)

Chemical structure diagram of the Human Insulin molecule, showing the amino acid sequences in the A-chain and B-chain with disulfide bonds connecting cysteine residues.*

FDA Label Image

Novolin N Relion Carton (Image 02)

Novolin N 100 U/mL injection suspension carton label for human insulin NPH (isophane insulin human suspension). The 10 mL multi-dose vial label by Novo Nordisk Pharmaceutical Industries, LP includes usage and storage instructions, warnings, and contact information for the manufacturer in Denmark.*

FDA Label Image

Image 03

Novolin N 100 IU/mL injection suspension carton label for subcutaneous use containing NPH (isophane insulin human suspension). The 10 mL multidose vial packaging shows usage instructions, warnings, storage conditions, and contact information for Novo Nordisk Pharmaceutical Industries, LP. The label features the ReliOn brand and is intended for retail sale by Walmart and Sam's Clubs.*

FDA Label Image

Image 04

Novolin N FlexPen 100 units/mL (U-100) injection, a human insulin isophane suspension for subcutaneous use. The packaging label shows 5 x 3 mL prefilled pens intended for single-patient use only. It includes manufacturer Novo Nordisk Pharmaceutical Industries, LP, and provides storage instructions, warnings, and handling information.*

FDA Label Image

Image 05

Novolin N FlexPen isophane insulin human suspension 100 units/mL (U-100) injection, suspension for subcutaneous use, presented in 5x3 mL prefilled pens. Labeler is Novo Nordisk Pharmaceutical Industries, LP. The carton includes directions for use, storage conditions, warnings, and manufacturer's details along with a barcode and trademark information.*

FDA Label Image

Image 13

Novolin N human insulin 100 IU/mL injection, suspension vial packaging. The carton is white with red and gray sections, showing the brand name Novolin N prominently. The labeler is Novo Nordisk Pharmaceutical Industries, LP. This product is intended for subcutaneous use.*

FDA Label Image

Image 14

An instructional diagram of the Novolin N FlexPen, a human insulin injection suspension device. The diagram labels parts including the pen cap, rubber stopper, 12 units marked on the cartridge, glass ball inside the cartridge, cartridge scale, dose pointer selector, and push button.*

FDA Label Image

Image 15

An instructional diagram showing components of NovoFine, NovoFine Plus, and NovoTwist needle systems used with Novolin N injection suspension. Each system's big outer needle cap, inner needle cap, needle, and protective tab are illustrated side-by-side for comparison.*

FDA Label Image

Image 16

Instructional diagram showing a person using a vial adapter with a syringe, illustrating how to connect and prepare for injection, likely related to subcutaneous administration of Novolin N Human Insulin suspension.*

FDA Label Image

Image 17

An instructional illustration showing two sequential steps involving a syringe and vial: a right hand holding a syringe pointing upward (step 1), and a left hand holding a vial horizontally (step 2). No text other than numeric step indicators is visible.*

FDA Label Image

Image 18

FDA Label Image

Image 19

Illustration showing instructions for use of the NovoFine and NovoFine Plus injection needles and the NovoTwist pen needle system. The images depict how to attach or remove the needle from an insulin pen for subcutaneous injection of Novolin N human insulin suspension.*

FDA Label Image

Image 20

An instructional illustration showing how to attach a NovoFine or NovoFine Plus needle to a NovoTwist pen injection device. The image depicts a hand holding the pen and the needle, with arrows indicating the direction for securing or twisting the needle on the pen.*

FDA Label Image

Image 21

Instructional diagram demonstrating the use of NovoFine and NovoTwist injectable needles, showing the proper grip and attachment technique for subcutaneous injection of Novolin N Human Insulin suspension.*

FDA Label Image

Image 22

Novolin N 100 [iU]/mL injection suspension carton and vial label by Novo Nordisk Pharmaceutical Industries, LP. The packaging indicates it is a human insulin injection for subcutaneous use, presented in a vial inside a rectangular carton.*

FDA Label Image

Image 23

Novolin N 100 IU/mL injection suspension for subcutaneous use in a vial, labeled by Novo Nordisk Pharmaceutical Industries, LP. The vial contains human insulin as the active ingredient and is intended for treatment use as indicated on the label.*

FDA Label Image

Image 24

Novolin N 100 IU/mL suspension for injection in a vial, a human insulin product from Novo Nordisk Pharmaceutical Industries, LP. The label indicates the product is intended for subcutaneous use.*

FDA Label Image

Image 25

An instructional illustration showing a hand adjusting the dose on a purple insulin injection pen, with an inset showing the pen dial displaying a selection of 2 units of human insulin. The image demonstrates how to select the dose by turning the dial on the pen.*

FDA Label Image

Image 26

An instructional illustration showing a hand holding a pen-like insulin injector device. The image indicates shaking or mixing the device before use, implying preparation of the Human Insulin injection suspension for subcutaneous administration.*

FDA Label Image

Image 27

An instructional illustration shows a hand holding a Novolin N injection pen and pushing the green dose button upward, indicating the action to prepare or dose the Human Insulin 100 IU/mL subcutaneous injection. An inset depicts a close-up of the pen needle attachment area, guiding how to secure the needle for use.*

FDA Label Image

Image 28

FDA Label Image

Image 29

An instructional illustration showing a hand pressing down on the plunger of a pen-like injection device. The device displays a dosage window indicating '0.5' units, suggesting dose setting or administration. The image depicts part of the subcutaneous injection procedure for a drug product.*

FDA Label Image

Image 30

Illustration showing a close-up of the tip of a syringe or injection device, likely representing proper subcutaneous injection technique for Novolin N human insulin suspension 100 [iU]/mL.*

FDA Label Image

Image 31

An instructional illustration showing a hand holding a pen-like device with an arrow pointing away from a cap, indicating removal of the cap by pulling it off. The image is related to preparing an injection device, likely for subcutaneous administration.*

FDA Label Image

Image 32

An instructional illustration showing a close-up of a blue insulin pen being dialed to select the dose. Two inset boxes indicate dose options of 5 units and 24 units selected on the pen's dose window, demonstrating how to adjust the dose by turning the dial before injection.*

FDA Label Image

Image 33

FDA Label Image

Image 34

FDA Label Image

Image 35

FDA Label Image

Image 36

FDA Label Image

Image 37

FDA Label Image

Image 38

FDA Label Image

Image 39

FDA Label Image

Image 40

FDA Label Image

Image 41

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.